Email this article to a friend
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
-
* Corresponding author: Juergen Braun j.braun@rheumazentrum-ruhrgebiet.de
Arthritis Research & Therapy 2005, 7:R439-R444 doi:10.1186/ar1693